设为首页收藏本站
开启辅助访问 切换到窄版

 找回密码
 To register

QQ登录

只需一步，快速开始

扫一扫，访问微社区

  • ALL
  • Journals
  • Books

派博传思国际中心 »期刊书目

› Journal of SCIE
› PHARMACOLOGY & PHARMACY(药理学与药学)

1234下一页
返回列表

SCIE期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy 2024/2025影响因子:1.473 (REV BRAS FARMACOGN) (

[复制链接]
查看: 44437|回复: 35
发表于 2025-3-21 17:43:39 | 显示全部楼层 |阅读模式
期刊全称Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
期刊简称REV BRAS FARMACOGN
影响因子20241.473
视频videohttp://file.papertrans.cn/27/26676/26676.mp4
ISSN0102-695X
eISSN1981-528X
出版商SPRINGERNATURE
发行地址CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
学科分类1.Science Citation Index Expanded (SCIE)--Chemistry, Medicinal | Pharmacology & Pharmacy; 2.Biological Abstracts--Chemistry, Medicinal | Pharmacology & Pharmacy; 3.BIOSIS Previews_BIOSIS Citation Index--Chemistry, Medicinal | Pharmacology & Pharmacy; 4.Essential Science Indicators--Pharmacology & Toxicology;
出版语言English, Portuguese
The information of publication is updating

SCIE(SCI)期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy(20 21 REV HIST)影响因子


SCIE(SCI)期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy(REV BRAS FARMACOGN)影响因子@(药理学与药学)学科排名


SCIE(SCI)期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy(20 21 REV HIST)总引论文


SCIE(SCI)期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy(REV BRAS FARMACOGN)总引论文@(药理学与药学)学科排名


SCIE(SCI)期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy(20 21 REV HIST)影响因子


SCIE(SCI)期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy(REV BRAS FARMACOGN)总引频次@(药理学与药学)学科排名


SCIE(SCI)期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy(20 21 REV HIST)即时影响因子


SCIE(SCI)期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy(REV BRAS FARMACOGN)即时影响因子@(药理学与药学)学科排名


SCIE(SCI)期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy(20 21 REV HIST)五年累积影响因子


SCIE(SCI)期刊Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy(REV BRAS FARMACOGN)五年累积影响因子@(药理学与药学)学科排名


单选投票, 共有 1 人参与投票
1.jpg
 

0票 0.00%

Perfect with Aesthetics
2.jpg
 

1票 100.00%

Better Implies Difficulty
3.jpg
 

0票 0.00%

Good and Satisfactory
4.jpg
 

0票 0.00%

Adverse Performance
5.jpg
 

0票 0.00%

Disdainful Garbage
您所在的用户组没有投票权限
gingerly
回复

举报

发表于 2025-3-21 21:11:47 | 显示全部楼层
mediocrity
回复

举报

发表于 2025-3-22 02:11:27 | 显示全部楼层
Submitted on: 24 June 2021. Revised on: 21 July 2021. Accepted on: 05 August 2021. Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
Oratory
回复

举报

发表于 2025-3-22 07:29:02 | 显示全部楼层
Submitted on: 21 February 2021. Revised on: 27 March 2021. Accepted on: 08 April 2021. Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
HEED
回复

举报

发表于 2025-3-22 12:13:31 | 显示全部楼层
Submitted on: 28 January 2012. Revised on: 06 March 2012. Accepted on: 01 April 2012. Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
做事过头
回复

举报

发表于 2025-3-22 13:56:38 | 显示全部楼层
deficiency
回复

举报

发表于 2025-3-22 18:49:48 | 显示全部楼层
Submitted on: 25 October 2006. Revised on: 12 November 2006. Accepted on: 26 November 2006. Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
construct
回复

举报

发表于 2025-3-22 22:08:38 | 显示全部楼层
Submitted on: 01 February 2014. Revised on: 04 March 2014. Accepted on: 18 March 2014. Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
exorbitant
回复

举报

发表于 2025-3-23 05:00:31 | 显示全部楼层
muster
回复

举报

发表于 2025-3-23 08:19:17 | 显示全部楼层
Submitted on: 25 May 2011. Revised on: 07 July 2011. Accepted on: 23 July 2011. Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
Dysarthria
回复

举报

下一页 »
1234下一页
返回列表
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-11-4 09:09
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表